Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia

BACKGROUND: Tigecycline, an expanded broad-spectrum glycylcycline, exhibits in vitro activity against many common pathogens associated with community-acquired pneumonia (CAP), as well as penetration into lung tissues that suggests effectiveness in hospitalized CAP patients. The aim of the present st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tanaseanu, Cristina, Milutinovic, Slobodan, Calistru, Petre I, Strausz, Janos, Zolubas, Marius, Chernyak, Valeriy, Dartois, Nathalie, Castaing, Nathalie, Gandjini, Hassan, Cooper, C Angel
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2009
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2753558/
https://ncbi.nlm.nih.gov/pubmed/19740418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2466-9-44
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge